Literature DB >> 34259175

Lophomonas isolation in sputum sample at Peru.

Jeel Moya-Salazar1, Richard Salazar-Hernandez2, Madeleine Lopez-Hinostroza3, Hans Contreras-Pulache4.   

Abstract

Lophomonas infection is an emerging parasitic disease causing respiratory infections. After China, Peru is the second country with the highest number of cases. In the bright-field microscopy evaluation of fresh samples, most of them are incorrectly estimated. Therefore, correct identification using cytological stains is to be supplemented. We report a case of a 29-year-old male with typical clinical symptoms of pneumonia, marked eosinophilia, and noninfiltrative pattern in chest X-ray, who had bronchopulmonary lophomoniasis.

Entities:  

Keywords:  Emerging disease; Lophomonas blattarum; parasite; pulmonary infection

Year:  2021        PMID: 34259175      PMCID: PMC8272432          DOI: 10.4103/lungindia.lungindia_696_20

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


INTRODUCTION

Lophomonas is a rising cause of parasitic lung infections in Peru, and Spain.[123] This flagellated protozoan can cause bronchopulmonary lophomoniasis (BPL) with nonspecific symptoms (cough, breathlessness, etc.), eosinophilia, and pulmonary infiltrate. Lophomonas blattarum and Lonchura Striata are the two main species that usually inhabit the intestines of cockroaches, termites, and mites. Therefore, in the environment infested by these insects, the risk of human infection is high, leading to respiratory failure. Since their identification by Lee and Brugerolle[4] at the beginning of the millennium, the observation of the morphological characteristics of parasites in biological samples has been conducted by bright-field microscopy techniques. Since Lophomonas cannot be cultured, their microscopic identification is based on the fresh and stained samples evaluation of sputum, bronchoalveolar lavage, and bronchial aspirate. To avoid identification errors, it is recommended to analyze the stained samples, mainly using Papanicolaou (Pap), Giemsa, or trichrome staining.[56] We report here a clinical case of Lophomonas infection in Peru.

CASE REPORT

A 29-year-old male patient arrived at the emergency department with chest pain, a productive cough, fever (approximately 38.5°), and throat inflammation. The processes related to typical pneumonia were ruled step by step: a smear microscopy and sputum culture was performed to search for Mycobacterium tuberculosis (negative result). Chest X-ray showed a noninfiltrative pattern, sputum cytology was negative for cancer (Pap stain), and the blood count showed eosinophilia (7%). The stool culture and the tests for Aspergillus fumigatus were also negative, and the value of C-reactive protein (average: 2.5 mg/L) and the erythrocyte sedimentation (average was 15 mm/h) was elevated. The rest of the clinical examination was unremarkable. Given the suspicious diagnosis of parasitic disease, fresh sputum sample was sent for microscopic evaluation (×400 and ×1000), and revealed pear-shaped organisms with linear flagellar movement [Figure 1a and Video Supplementary 1 data]. Pap slides confirmed this finding [Figure 1b], and we also performedMasson's trichome and Giemsa staining to describe in detail the characteristics of the parasites present in the sample [Figure 1c and d].
Figure 1

Lophomona in sputum sample. (a) Fresh sample. (b) Papanicolaou stain. (c) Giemsa stain. (d) Masson's trichome stain

Lophomona in sputum sample. (a) Fresh sample. (b) Papanicolaou stain. (c) Giemsa stain. (d) Masson's trichome stain Paracetamol, cetirizine, and cephalexin were administered for 4 days. Given the cytologic diagnosis, metronidazole was used for a week. The clinical manifestations improved rapidly 2 to 3 weeks after starting of antiparasitic treatment, with complete resolution at 5 weeks.

DISCUSSION

Although this finding establishes a link between Lophomoniasis causing-respiratory disease, its scrutiny is misestimated on a daily workflow. Therefore, lung infection is rejected as the cause of respiratory disease. Although advances in molecular techniques[7] may reduce these problems, they are still challenges in identifying BPL. The fresh observation of this flagellated parasite measuring 60 × 20 μ can be confused with ciliated cells or may be unnoticed in its evaluation. For this reason, the use of stained smears is suggested for the microscopic evaluation of its characteristics. This study also demonstrated the usefulness of other staining techniques that allow us to observe this protozoan present in samples from patients with respiratory disease. BLP has been reported in patients with some degree of immunosuppression such as with hematopoietic transplantation[8] or leukemia,[9] in patients with sinusitis,[10] asthma,[11] tuberculosis,[12] and also in the immunocompetent population.[13] In this case, the clinical manifestations of BPL in an immunocompetent patient have significant eosinophilia consistent with previous reports.[3] To date, several studies have focused on L. blattarum infection, and rare cases of BPL are becoming more frequent. In the case of Peru, which has about 10% of case reports, the northern populations are more affected, of reported cases, the northern populations are the most affected, with patients from the Intensive Care Units being the most affected.[1415] Further studies are required to understand whether L. blattarum is endemic. Finally, the case report and documentation of the parasite are essential for understanding the pathophysiological processes of its human infection, improving diagnostic methods, and promoting preventive measures against the parasite that causes BPL.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  11 in total

1.  [Lung infection by lophomonas spp. in a female patient with acute myeloid leukemia].

Authors:  Claudio Vidal; Elizabeth Barthel; María de Los Ángeles Rodríguez
Journal:  Rev Peru Med Exp Salud Publica       Date:  2018 Jul-Sep

2.  Lophomonas misidentification in bronchoalveolar lavages.

Authors:  Rafael Martínez-Girón; Hugo Cornelis van Woerden; Levent Doganci
Journal:  Intern Med       Date:  2011-11-01       Impact factor: 1.271

3.  Dual infection with pulmonary tuberculosis and Lophomonas blattarum in India.

Authors:  Santwana Verma; Ghanshyam Verma; Dig Vijay Singh; Jitender Mokta; Rameshwar Singh Negi; Anupama Jhobta; Anil Kanga
Journal:  Int J Tuberc Lung Dis       Date:  2015-03       Impact factor: 2.373

4.  Identification criteria of the rare multi-flagellate Lophomonas blattarum: comparison of different staining techniques.

Authors:  Yosra Hussein Alam-Eldin; Amany Mamdouh Abdulaziz
Journal:  Parasitol Res       Date:  2015-06-03       Impact factor: 2.289

5.  First Molecular Diagnosis of Lophomoniasis: the End of a Controversial Story.

Authors:  Mahdi Fakhar; Maryam Nakhaei; Ali Sharifpour; Hamed Kalani; Elham Sadat Banimostafavi; Siavash Abedi; Sepideh Safanavaei; Masoud Aliyali
Journal:  Acta Parasitol       Date:  2019-06-05       Impact factor: 1.440

6.  Late onset pulmonary Lophomonas blattarum infection in renal transplantation: a report of two cases.

Authors:  Qiang He; Xiuju Chen; Bo Lin; Lihui Qu; Jianyong Wu; Jianghua Chen
Journal:  Intern Med       Date:  2011-05-01       Impact factor: 1.271

7.  Bronchopulmonary infection by Lophomonas blattarum in a pediatric patient after hematopoietic progenitor cell transplantation: first report in Mexico.

Authors:  Napoleón González Saldaña; Francisco Javier Otero Mendoza; Francisco Rivas Larrauri; Diego Mauricio Galvis Trujillo; Edna Venegas Montoya; Eduardo Arias De La Garza; Hugo Juárez Olguín
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  [Lophomonas sp. in respiratory tract secretions in hospitalized children with severe lung disease].

Authors:  Rito Zerpa; Elsa Ore; Lilian Patiño; Yrma A Espinoza
Journal:  Rev Peru Med Exp Salud Publica       Date:  2010 Oct-Dec

9.  First Case Report of Sinusitis with Lophomonas blattarum from Iran.

Authors:  Fariba Berenji; Mahmoud Parian; Abdolmajid Fata; Mahdi Bakhshaee; Fereshte Fattahi
Journal:  Case Rep Infect Dis       Date:  2016-02-04

10.  Lophomonas blattarum infection in immunocompetent patient.

Authors:  Rahul Tyagi; Kavita Bala Anand; Kishore Teple; Rajkumar Singh Negi
Journal:  Lung India       Date:  2016 Nov-Dec
View more
  3 in total

1.  Molecular Evidence of Emerged Pulmonary Lophomoniasis due to Lophomonas blattarum among Hospitalized Patients in Southwestern Iran: A National Registry-Based Study.

Authors:  Kobra Mokhtarian; Simin Taghipour; Maryam Nakhaei; Amirmasoud Taheri; Ali Sharifpour; Mahdi Fakhar; Hajar Ziaei Hezarjaribi
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-05-25

2.  First report of Lophomonas infection in a patient with AML-2 from Qeshm Island, Persian Gulf, southern Iran.

Authors:  Ali Sharifpour; Hossein Zarrinfar; Mahdi Fakhar; Zakaria Zakariaei; Mostafa Soleymani; Elham Sadat Banimostafavi; Maryam Nakhaei
Journal:  Respirol Case Rep       Date:  2022-01-26

3.  Fungal, parasitological, and bacterial coinfection in a severely ill COVID-19 patient in Peru.

Authors:  Jeel Moya-Salazar; Sharon S Sauñe; Roxana Valer; Richard Salazar-Hernandez; Wilfredo Loza; Evelyn Suxe; Karina Chicoma-Flores; Hans Contreras-Pulache
Journal:  Clin Case Rep       Date:  2022-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.